Intracerebral Haemorrhage clinical trials

Explore recruiting intracerebral haemorrhage clinical trials.

Recruiting intracerebral haemorrhage studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Intracerebral Haemorrhage trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy of prophylactic levetiracetam for improving functional outcome in the acute phase of intracerebral haemorrhage: a randomised, double-blind, placebo-controlled, phase 3 trial PEACH 2

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Anakinra in Cerebral haemorrhage to Target secondary Injury resulting from Neuroinflammation - a phase II clinical trial

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Avoid Anticoagulation After IntraCerebral Haemorrhage

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Antiplatelet Secondary Prevention International Randomised study after INtracerebral haemorrhaGe - SM

Netherlands, Belgium

Therapeutic use (Phase IV) EU CTIS Study details

A Phase IIa, Randomized, Open-label, Proof-of-Concept Study to Evaluate Safety, Tolerability and Efficacy of Ir CPI in Patients with Spontaneous Intracerebral Haemorrhage - the BIRCH study

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Tranexamic acid for hyperacute spontaneous IntraCerebral Haemorrhage (TICH-3)

Sweden, France, Denmark, Spain, Norway, Ireland +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Intracerebral Haemorrhage trials by city

Intracerebral Haemorrhage in Toronto Intracerebral Haemorrhage in Vancouver Intracerebral Haemorrhage in Montreal Intracerebral Haemorrhage in Calgary Intracerebral Haemorrhage in Edmonton Intracerebral Haemorrhage in Ottawa Intracerebral Haemorrhage in Winnipeg Intracerebral Haemorrhage in Quebec City Intracerebral Haemorrhage in Hamilton Intracerebral Haemorrhage in Kitchener Intracerebral Haemorrhage in London Intracerebral Haemorrhage in Halifax Intracerebral Haemorrhage in New York Intracerebral Haemorrhage in Los Angeles Intracerebral Haemorrhage in Chicago Intracerebral Haemorrhage in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease